Medgene Granted Second License for Innovative Platform Vaccine to Enhance Pork Industry Solutions

Jun 14, 2023

Leading animal health company Medgene has been granted a second license by the USDA Center for Veterinary Biologics (CVB) to produce and market a groundbreaking Platform Vaccine for the pork industry. This USDA-approved license allows Medgene to leverage their Platform technology and develop vaccines addressing critical diseases in pigs, including Rotavirus, Porcine Circovirus, Influenza A, and Sapovirus.

Medgene's vaccine approach is built on a revolutionary "platform technology" that offers safety and adaptability for addressing multiple animal disease targets. By employing this technology, Medgene can rapidly develop vaccines and gain insights into the transmission of diseases across species and geographies, significantly reducing the time required compared to traditional vaccine development approaches.

Dr. Clayton Johnson, Director of Veterinary Services for Carthage Veterinary Service, LTD, lauded Medgene's Platform Vaccines, emphasizing how they enable the maintenance of high animal health standards.

The announcement of Medgene's licensure took place on June 8 at the World Pork Expo held in Des Moines, Iowa. Mark Luecke, CEO of Medgene, expressed the significance of the pork industry to the nation's food supply and highlighted the company's long-standing efforts to make the power of Platform technology accessible to pork industry veterinarians. With the license, Medgene can now provide the industry with safe, efficient, and cost-effective vaccine solutions.

Licensed veterinarians can now access Medgene's innovative vaccines for Rotavirus, Porcine Circovirus, Influenza A, and Sapovirus. These vaccines promise to revolutionize disease prevention and management within the pork industry, safeguarding animal health and enhancing the overall productivity and sustainability of pork production.

Source : pennsylvaniaagconnection

Video: Five Confirmed New World Screwworm Cases Raise Alarm for Livestock and Pet Owners

Pat Hoffmann, Swine Technical Consultant at Elanco Animal Health tells us about the impact of New World Screwworm. The emergence of New World screwworm in the U.S. creates a threat for veterinarians, livestock producers and pet owners that has not been seen north of the Florida Keys since the fly was eradicated from the United States more than 50 years ago. New World screwworm (Cochliomyia hominivorax) larvae feed on living tissue and can affect a wide range of warm-blooded animals, including livestock, companion animals, wildlife, and even humans.
“New World screwworm could have a devastating impact on animal health, welfare, and producer livelihoods,” said Jeff Simmons, President and CEO, Elanco Animal Health. “We want to thank the FDA, EPA and USDA, for all their work to prepare for this threat. We’re committed to supporting our customers during this challenging time by delivering innovation, scientific expertise, and available resources to help treat New World screwworm and support the health and well-being of animals.”
Elanco is working alongside the U.S. animal health industry to help them fight against this parasite, offering a portfolio of options for pets and livestock that can help treat New World screwworm larvae infestations.